Results 81 to 90 of about 8,456 (172)

Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression.

J Clin Endocrinol Metab
Lanzolla G, Saba F, Corrias S, Lixi F, Faa G, Colleo A, Mura C, Canu GL, Cappellacci F, Cuccu A, Giannaccare G, Mariotti S, Boi F.   +12 more
europepmc   +1 more source

Selenium Supplementation in Graves' Orbitopathy: Effects on Blood Concentrations and Clinical Outcomes. [PDF]

Clin Ophthalmol
Lumyongsatien M, Vejsitthangkul K, Treebuppachatsakul T, Sintuwong S, Nimitwongsakul O, Pongpirul K.   +5 more
europepmc   +1 more source

Thyroid orbitopathy

, 2012
BARTALENA, LUIGI, TANDA, MARIA LAURA PIERA   +1 more
  +5 more sources

Thyroid Eye Disease, Glycemic Control, and the Role of a One-Stop Clinic Approach: A Retrospective Audit Study. [PDF]

Cureus
Carter K, Khan Z, Mahamud B, Hussein F, Abdullah A, Simon G, Mlawa G.   +6 more
europepmc   +1 more source

Cigarette smoking exposure and clinical outcomes in Graves' disease.

J Clin Endocrinol Metab
Forbes S, Loo M, Tee SA, Stewart K, Vernazza J, Carroll L, Vennart N, Bartholomew P, Narayanan K, Tsatlidis V, Razvi S.   +10 more
europepmc   +1 more source

Effectiveness of Selenium Supplementation in the Treatment of Graves-Basedow Disease: A Scoping Review. [PDF]

Med Sci (Basel)
Vargas-Uricoechea H, Castellanos-Pinedo A, Urrego-Noguera K, Pinzón-Fernández MV, Meza-Cabrera IA, Vargas-Sierra H.   +5 more
europepmc   +1 more source

Case Reports of Teprotumumab as Treatment for Monoclonal Antibody-Induced Thyroid Orbitopathy. [PDF]

Reports (MDPI)
Moon J, Duncan N, Yorio J, Meltzer E, Aung MH.   +4 more
europepmc   +1 more source

Editorial: Thyroid eye disease. [PDF]

Front Ophthalmol (Lausanne)
Kahana A, Cho RI, Dave TV, Quaranta-Leoni FM, Strianese D.   +4 more
europepmc   +1 more source

Diagnostic Approaches to and Disaese Course Modifying Therapies in Graves Orbitopathy

Graves' Orbitopathy (GO) is an autoimmune condition that primarily affects the orbit, causing inflammation, muscle expansion, and tissue changes. Although often linked to Graves' Disease (GD), 5-10% of GO patients may not have GD at diagnosis.
Muthomi, Brenda Shey Wanjira
core  

Development of Graves orbitopathy after thyroidectomy for thyroid cancer. [PDF]

JCEM Case Rep
Hormiz M, Sydenham-Clarke L, Lammoza N, Zajac JD, Grossmann M, Lau LH.   +5 more
europepmc   +1 more source